Found: 10
Select item for more details and to access through your institution.
Eosinophils in the gastrointestinal tract : friends or foes?
- Published in:
- Acta Gastro-Enterologica Belgica, 2012, v. 75, n. 3, p. 310
- By:
- Publication type:
- Article
How to measure disease activity in eosinophilic esophagitis.
- Published in:
- Diseases of the Esophagus, 2016, v. 29, n. 8, p. 959, doi. 10.1111/dote.12391
- By:
- Publication type:
- Article
A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families.
- Published in:
- Allergy, 2016, v. 71, n. 6, p. 889, doi. 10.1111/all.12879
- By:
- Publication type:
- Article
Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.
- Published in:
- Allergy, 2015, v. 70, n. 12, p. 1633, doi. 10.1111/all.12733
- By:
- Publication type:
- Article
Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
- Published in:
- Allergy, 2014, v. 69, n. 9, p. 1248, doi. 10.1111/all.12455
- By:
- Publication type:
- Article
Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 8, p. 1000, doi. 10.1111/apt.13370
- By:
- Publication type:
- Article
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 8, p. 977, doi. 10.1111/apt.13363
- By:
- Publication type:
- Article
Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 5, p. 540, doi. 10.1111/apt.13307
- By:
- Publication type:
- Article
Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 6, p. 603, doi. 10.1111/apt.12636
- By:
- Publication type:
- Article
Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 11/12, p. 1084, doi. 10.1111/apt.12087
- By:
- Publication type:
- Article